Optical coherence tomography (OCT) is a relatively new technology for performing high-resolution, cross-sectional imaging of tissue structure on the micron scale in situ and in real time. OCT has emerged as a powerful optical imaging instrument and technology. OCT performs high-resolution, cross-sectional tomographic imaging of the internal structure in 3-D materials, including biological tissues.
The features of OCT that make it an important technology for biomedical imaging, ophthalmic imaging, nontransparent tissue imaging are where conventional excisional biopsy is hazardous or impossible, and/or cases in which conventional biopsy has an unacceptably high false negative rate because of sampling errors and to provide guidance during surgical interventional procedures.
The development of high-resolution and high-speed OCT technology as well as OCT compatible catheter/endoscopes and other delivery systems represent the future of OCT imaging clinical applications. The unique capabilities of OCT imaging make it an ideal choice for the diagnosis and clinical management of many diseases. In 2015, the total revenue of the intravascular OCT market was $128 million; it increased to $140 million in 2016.
The primary factors contributing in the growth of the Optical Coherence Tomography (OCT) market is growing aging population and extensive application scope of the technology. Moreover, technological benefits of OCT such as ability to visualize in-depth structures of the eye, mucosal membranes, surface tissues and vascular systems; is significantly driving the growth of the Optical Coherence Tomography (OCT) market. Furthermore, extensive use of OCT devices in drug discovery and development for imaging biological tissues at the molecular level are also contributing in the growth of the Optical Coherence Tomography (OCT) market. However, restraining factors such as lack of reimbursement facilities and insufficient clinical data might impede the growth of the Optical Coherence Tomography (OCT) market.
Some of the major companies involved with the Optical Coherence Tomography (OCT) market are Agfa Healthcare, Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Imalux Corporation, Michelson Diagnostics, Novacam Technologies Inc., OPTOPOL Technology S.A., Topcon Medical Systems Inc. and Thorlabs Inc.